Hereditary sensory and autonomic neuropathy type 1 is a rare genetic nerve disorder that mainly affects feeling in the feet and hands. People with HSAN1 often notice numbness, burning pain, or injuries that heal slowly, and some have dry skin or trouble sweating. Symptoms usually begin in adolescence or adulthood and tend to worsen over time. Many people with Hereditary sensory and autonomic neuropathy type 1 live for many years, but complications like infections and foot ulcers can be serious. Treatment focuses on pain control, foot and skin care, infection prevention, mobility support, and genetic counseling.
Overview
Hereditary sensory and autonomic neuropathy type 1Symptoms
Hereditary sensory and autonomic neuropathy type 1 causes gradual numbness, tingling, burning pain, and reduced ability to feel temperature or pain, usually starting in the feet. People may get foot injuries or ulcers, infections, and abnormal sweating or fainting.
Outlook and prognosis
Most people with hereditary sensory and autonomic neuropathy type 1 live a typical lifespan, but face lifelong sensory loss, pain crises, and foot ulcers that can lead to infections. Early symptom recognition, protective foot care, and tailored pain management often prevent complications. Regular check-ins with neurology and foot specialists help maintain mobility and independence.
Causes and risk factors
Hereditary sensory and autonomic neuropathy type 1 is caused by harmful changes in SPTLC1 or SPTLC2, usually autosomal dominant, sometimes new. The key risk is an affected parent. Coexisting nerve stressors—diabetes, alcohol misuse, smoking, repetitive injuries—increase complications, not cause it.
Genetic influences
Genetics are central in Hereditary sensory and autonomic neuropathy type 1, which is usually caused by inherited variants in specific genes. Most cases follow an autosomal dominant pattern, so a single altered gene can lead to symptoms. Genetic testing can confirm HSAN1, guide family planning, and inform prognosis.
Diagnosis
Hereditary sensory and autonomic neuropathy type 1 is diagnosed by clinical features and nerve tests, while excluding other causes. A blood-based genetic test confirms the genetic diagnosis of Hereditary sensory and autonomic neuropathy type 1 and supports family screening.
Treatment and drugs
Treatment for hereditary sensory and autonomic neuropathy type 1 focuses on protecting feeling-impaired feet and hands, easing nerve pain, and supporting autonomic symptoms. Plans often include podiatry, wound care, custom footwear, duloxetine or gabapentin, and physical therapy. Genetic counseling, mental health support, and regular check-ins help adjust care over time.
Symptoms
Day to day, many people first notice changes in their feet—less feeling for heat, cold, or pain, and more minor injuries than expected. These early features of Hereditary sensory and autonomic neuropathy type 1 (HSAN1) often start gradually and may spread from the feet to the hands over time. You may also feel burning or electric-like pain even when the skin looks normal. A healthcare professional can help sort out what’s typical aging and what warrants a closer look.
Numbness and reduced ability to feel heat, cold, or pain often begins in the feet and later affects the hands. This raises the risk of burns or injuries you might not notice right away. Hereditary sensory and autonomic neuropathy type 1 commonly follows this pattern.
Cuts, blisters, or burns may not hurt, so they can go unnoticed. This can lead to deeper sores on the feet or hands if not spotted early.
Burning, stabbing, or electric-shock pain can occur even when the skin looks normal. Light touch or nighttime rest can sometimes make the pain feel worse.
Loss of position sense can make walking on uneven ground or in the dark unsteady. You may find yourself tripping more or widening your stance for stability.
How people usually first notice Hereditary sensory and autonomic neuropathy type 1?
People often first notice hereditary sensory and autonomic neuropathy type 1 when pain and temperature sensation start to fade in the feet and hands, leading to painless cuts, burns, or slow-healing ulcers that seem to “appear out of nowhere.” For many, the first signs of hereditary sensory and autonomic neuropathy type 1 show up in adolescence or adulthood as numbness, tingling, or burning feelings in the toes, frequent foot injuries, or unexplained infections, sometimes along with very dry skin or reduced sweating. Families may connect the dots when multiple relatives have similar nerve symptoms or repeated foot problems, prompting a clinician to consider this inherited neuropathy.
Types of Hereditary sensory and autonomic neuropathy type 1
Hereditary sensory and autonomic neuropathy type 1 (HSAN1) has several genetic variants that can look slightly different in when symptoms start and which nerves are most affected. All forms mainly damage the long sensory nerves, leading to numbness, pain loss, and foot ulcers; some also add shooting pain, weakness, or hearing problems. People may notice different sets of symptoms depending on their situation. When reading about types of HSAN1, you’ll see names tied to the specific gene involved; these variants help explain why symptoms vary within families and across age groups.
SPTLC1 variant
Often begins in the teens to 30s with numbness and reduced pain sensation in the feet, then hands. Painful nerve attacks can occur, and foot ulcers or infections are common. Some develop mild weakness over time.
SPTLC2 variant
Similar length‑dependent sensory loss in legs and feet, with burning pain in some. Onset can be a bit later than other types and may progress slowly. Balance issues can develop as numbness climbs up the legs.
ATL1 variant
Sensory loss in the feet is typical, but mild leg stiffness or spasticity can appear. This variant can blur with spastic paraplegia features. Early symptoms of HSAN1 may be subtle, like frequent foot injuries you don’t feel.
DNMT1 variant
Sensory neuropathy combines with early adult‑onset hearing loss and sometimes vision or cognitive changes. Numbness and ulcers resemble other HSAN1 types but with added hearing problems. Sleep or memory issues can emerge over time.
RARβ (RARB) variant
Sensory loss and pain insensitivity are present, sometimes with eye movement or retinal findings. Foot ulcers and slow‑healing wounds remain a risk. Severity can vary within the same family.
NGF variant
Reduced pain sensation is prominent from earlier in life with fewer pain signals reaching the brain. People may experience painless injuries and temperature detection problems. Sweating changes can occur in some.
SCN9A variant
Sensory symptoms can include burning pain episodes alongside numbness. Heat or cold may trigger pain flares. Over time, reduced sensation increases the risk of unnoticed injuries.
HSAN1E (DNMT1)
This label is often used for the DNMT1‑related form, highlighting the pattern of neuropathy plus hearing loss and cognitive changes. Symptoms typically start in early to mid‑adulthood. Among the types of HSAN1, this one tends to include more non‑nerve features.
What genetics can tell you about symptoms
Some people with HSAN1 who carry SPTLC1 or SPTLC2 changes develop burning pain, numbness, or loss of feeling in the feet and hands first, often leading to unnoticed injuries. Certain variants raise toxic sphingolipids, which damage long sensory nerves and can also reduce sweating or cause blood pressure swings.
Causes and risk factors
Hereditary sensory and autonomic neuropathy type 1 is caused by changes in genes that affect nerve function, often in SPTLC1 or SPTLC2. Genes set the stage, but environment and lifestyle often decide how the story unfolds. Risk for Hereditary sensory and autonomic neuropathy type 1 is higher if a parent carries the change, though a new change can arise. Age can shape when symptoms begin and how fast they progress. Smoking, heavy alcohol use, long-term high blood sugar, and repeated injuries can worsen nerve problems and complications.
Environmental and biological risk factors
Understanding what can raise the chance of Hereditary sensory and autonomic neuropathy type 1 can help with family planning. Doctors often group risks into internal (biological) and external (environmental). For this condition, the meaningful factors mainly relate to age at conception and rare situations that can harm DNA in sperm or egg cells. Below are biological and environmental risk factors for Hereditary sensory and autonomic neuropathy type 1.
Conception with an older father is linked to a slightly higher chance of a brand-new change in a gene. This small increase can raise the odds of conditions like Hereditary sensory and autonomic neuropathy type 1 starting in a family for the first time. Most babies of older fathers are healthy.
Very high levels of ionizing radiation to a parent’s pelvis or whole body can damage DNA in sperm or egg cells. This may slightly increase the chance of a new condition caused by a change in one gene, though such exposures are rare. Routine X-rays or airport scanners use far lower doses.
Some cancer treatments, especially certain chemotherapies or pelvic radiation, can injure DNA in reproductive cells. Conception too soon after treatment may carry a slightly higher chance of new DNA changes. Care plans often include a waiting period to lower this risk.
Even without identifiable exposures, spontaneous DNA copying errors can occur when sperm or eggs form. This background chance explains why a condition like Hereditary sensory and autonomic neuropathy type 1 can rarely appear in a child with no prior family history.
Genetic risk factors
Genetic changes are the primary cause of Hereditary sensory and autonomic neuropathy type 1, most often running in families in an autosomal dominant way. Several genes can be involved, including SPTLC1, SPTLC2, DNMT1, and ATL3, and each can shape when symptoms start and how severe they become. Risk is not destiny—it varies widely between individuals. Knowing the gene involved can help families watch for early symptoms of Hereditary sensory and autonomic neuropathy type 1 and understand who in the family may be at higher risk.
Autosomal dominant inheritance: Each child of an affected parent has a 50% chance to inherit the gene change that causes Hereditary sensory and autonomic neuropathy type 1. Both males and females can be affected, and severity can differ. Some relatives may remain symptom-free until later adulthood.
SPTLC1 variants: Changes in SPTLC1 are a leading cause of Hereditary sensory and autonomic neuropathy type 1. They alter fat-building pathways in nerve cells, leading to a build-up of nerve-toxic molecules that damage long sensory fibers. Many families see symptoms begin in the teens to mid-adulthood.
SPTLC2 variants: Less common than SPTLC1 changes. They affect the same pathway and can produce a similar nerve-damage pattern. Age at onset and severity can differ between families.
DNMT1 variants: DNMT1 changes cause a subtype that often includes hearing loss and memory or thinking changes. Onset usually occurs in adulthood. Family lines may show both nerve problems and these broader neurologic features.
ATL3 variants: ATL3 changes cause a form sometimes labeled HSAN1F. They disrupt how nerve cells form and maintain their internal connections, affecting long nerves first. This can lead to slowly progressive sensory loss in the feet and hands.
De novo variants: Sometimes the gene change appears for the first time in a person, with no prior family history. That person can still pass it to each child with a 50% chance. This can make the condition seem sporadic in a family.
Variable expressivity: The same genetic change can lead to very different experiences in relatives. Some have mild issues, while others are more affected. Even within one family, age at onset can differ by decades.
Genetic heterogeneity: Several different genes can cause Hereditary sensory and autonomic neuropathy type 1. Knowing which gene is involved can help with prognosis and family planning. In some cases, genetic testing can give a clearer picture of your personal risk.
Lifestyle risk factors
Lifestyle habits do not cause Hereditary sensory and autonomic neuropathy type 1, but they can meaningfully influence injuries, pain, wound healing, and complications. Choices around footwear, activity, skin care, and substances can change day-to-day safety and long-term outcomes. Understanding how lifestyle affects Hereditary sensory and autonomic neuropathy type 1 helps target what you can control.
Well-fitted, cushioned shoes and seamless socks reduce pressure points that can lead to ulcers in numb feet. Avoiding barefoot walking lowers the risk of unnoticed cuts and burns.
Inspecting feet and hands every day catches blisters, cracks, or foreign objects early. Prompt cleaning and dressing of even minor injuries can prevent serious infections.
Low-impact exercise and balance training improve stability and reduce fall and fracture risk. Avoid repetitive pounding or high-heat activities that can worsen tissue damage you may not feel.
Numbness increases burn and frostbite risk from hot baths, heating pads, or cold exposure. Test water with an intact-sensation body part and use protective gloves and socks in extremes.
Risk prevention
Hereditary sensory and autonomic neuropathy type 1 is genetic, so you can’t fully prevent the condition itself, but you can lower the risk of injuries, infections, and avoidable complications. Paying attention to early symptoms of hereditary sensory and autonomic neuropathy type 1—like numb feet, painless cuts, or balance changes—helps you act sooner. Knowing your risks can guide which preventive steps matter most. Partner with your care team to tailor a plan that fits your life and health background.
Ask about carrier testing, family planning options, and the chance of passing hereditary sensory and autonomic neuropathy type 1 to children. A genetic counselor can explain choices like prenatal testing or IVF with embryo testing.
See clinicians regularly for nerve checks, foot exams, and monitoring of blood pressure and sweating problems. Early treatment of changes can prevent small issues from becoming big setbacks.
Look over feet and lower legs every day for blisters, cracks, redness, or swelling. Catching skin problems early helps prevent ulcers and bone infections.
Wear cushioned, well-fitted shoes and seamless, moisture‑wicking socks. This lowers rubbing and pressure that can lead to sores in hereditary sensory and autonomic neuropathy type 1.
Transmission
Hereditary sensory and autonomic neuropathy type 1 (HSAN1) is not contagious; it doesn’t spread through touch, air, or shared items. HSAN1 is usually passed down in families in a dominant way—if one parent has HSAN1, each child has a 1 in 2 (50%) chance to inherit the altered gene and, over time, develop symptoms. Rarely, HSAN1 can appear for the first time in a family because of a new genetic change in the egg or sperm. Because symptoms often begin in adulthood and can vary in severity, a parent may have mild or unrecognized signs when a child is born. If you’re wondering about how Hereditary sensory and autonomic neuropathy type 1 is inherited, a genetics professional can review the genetic transmission of Hereditary sensory and autonomic neuropathy type 1 in your family.
When to test your genes
Consider genetic testing if you have unexplained burning pain, numbness, or injuries you don’t feel, especially if several relatives had similar symptoms or early foot ulcers and amputations. Testing is also reasonable before pregnancy or if a close relative has a confirmed SPTLC1/2 variant. Results can guide nerve care, pain management, injury prevention, and family planning.
Diagnosis
For many, the first step comes when everyday activities start feeling harder—like not noticing a blister on the foot or cuts that don’t hurt—prompting an evaluation. In hereditary sensory and autonomic neuropathy type 1, clinicians look for a recognizable pattern of lifelong sensory loss and skin injuries, then confirm it with targeted tests. Family history is often a key part of the diagnostic conversation. The goal is a clear, genetic diagnosis of Hereditary sensory and autonomic neuropathy type 1 so care can be tailored and risks managed.
Doctors look for slowly progressive loss of pain and temperature sensation, often starting in the feet and hands. Recurrent painless injuries, ulcers, or infections support the suspicion. Reduced sweating or other autonomic changes may be present.
The exam checks touch, vibration, temperature, and pain sensation as well as reflexes and muscle strength. Findings typically show sensory loss out of proportion to weakness. Skin and nail changes from repeated injuries can also be noted.
A multigenerational pattern of similar symptoms can point toward an inherited neuropathy. Gathering details on ages of onset, limb ulcers, and surgeries (like toe amputations) helps map a pattern. This context guides which tests to order first.
These tests measure how well signals travel along the nerves. Results in HSAN1 may be normal early or show sensory nerve changes over time. They help distinguish sensory-predominant neuropathy from other nerve problems.
Stages of Hereditary sensory and autonomic neuropathy type 1
Hereditary sensory and autonomic neuropathy type 1 does not have defined progression stages. Symptoms can build slowly and unevenly—numbness, burning pain, or foot ulcers may change over years—so doctors track changes with exams and nerve tests rather than placing people into fixed stages. Different tests may be suggested to help confirm the cause and rule out other conditions. Evaluation usually includes a discussion of early symptoms of hereditary sensory and autonomic neuropathy type 1, a neurological exam, nerve conduction studies, and genetic testing to confirm the diagnosis and inform care for you and possibly your family.
Outlook and prognosis
Daily routines often adapt as people with Hereditary sensory and autonomic neuropathy type 1 learn ways to protect their feet and hands, watch skin for injuries, and manage pain flares. The outlook is not the same for everyone, but most face a slowly progressive loss of feeling in the feet and, later, the hands. That loss of protective sensation raises the risk of unnoticed cuts, burns, and pressure sores that can get infected. Some also develop shooting or burning nerve pain, balance troubles, or mild changes in sweating and blood pressure control. In medical terms, the long-term outlook is often shaped by both genetics and lifestyle.
Looking at the long-term picture can be helpful. Many people with Hereditary sensory and autonomic neuropathy type 1 stay active and independent for years by combining regular foot care, well‑fitting shoes, and prompt treatment of wounds with pain management strategies. Serious complications—deep infections, bone changes in the foot, or amputations—are largely tied to unrecognized injuries and delayed care. Early symptoms of Hereditary sensory and autonomic neuropathy type 1 often start in adolescence or adulthood and progress slowly; life expectancy is usually near normal when infections and cardiovascular risks are managed, though severe, untreated infections can become life‑threatening.
Understanding the prognosis can guide planning and day‑to‑day choices—think protective gloves for hot pans, daily skin checks, and low‑impact exercise to support balance. With ongoing care, many people maintain work, family life, and hobbies, even if adjustments are needed over time. Talk with your doctor about what your personal outlook might look like, including pain control options, fall‑prevention strategies, and when to seek urgent care for a wound.
Long-term effects
Day to day, many people notice reduced feeling in the feet and hands that slowly spreads over years, bringing risks you can’t always feel in the moment. Hereditary sensory and autonomic neuropathy type 1 tends to progress gradually, with periods of stability and times when symptoms advance. Long-term effects vary widely, and not everyone has the same mix or severity. Over time, daily routines may shift—from checking feet more often to choosing shoes with extra protection—because minor injuries can go unnoticed and turn serious.
Feeling in the toes and feet fades first, then may spread to the hands. This can make heat, cold, or pain hard to sense, raising injury risk.
Some have ongoing burning, stabbing, or electric-like pain despite numbness. Pain can flare at night and disrupt sleep over time.
Small blisters or cuts can become slow-healing sores on the feet. Without pain as a warning, ulcers can deepen and be hard to clear.
Untreated sores may lead to skin and deep bone infections. In severe cases, this can end in partial toe or foot amputation.
How is it to live with Hereditary sensory and autonomic neuropathy type 1?
Living with hereditary sensory and autonomic neuropathy type 1 often means managing reduced or absent pain sensation in the feet and hands, frequent injuries you may not notice right away, and slow-healing wounds that can lead to infections or ulcers. Daily life can involve careful foot and hand checks, protective footwear, temperature awareness, and planning around mobility changes or neuropathic pain flares. For many, this also affects family and friends, who may help with skin checks, wound care, and transportation, and who share in the vigilance needed to prevent complications. With a consistent routine and support from clinicians, people can reduce risks, stay active, and protect independence.
Treatment and drugs
Treatment for hereditary sensory and autonomic neuropathy type 1 (HSAN1) focuses on protecting feeling in the feet and hands, preventing injuries and infections, and easing pain. Supportive care can make a real difference in how you feel day to day, including regular foot checks, well‑fitting shoes or custom insoles, prompt wound care, and physical therapy to keep balance and strength. For nerve pain, doctors often use medicines like gabapentin, pregabalin, duloxetine, or certain tricyclics; a doctor may adjust your dose to balance benefits and side effects, and topical options (such as lidocaine patches) may help small, localized areas. People with slow‑healing ulcers may need antibiotics for infections and sometimes care from a podiatrist or wound clinic, while dry eyes or reduced sweating can be managed with lubricating eye drops, skin moisturizers, and careful temperature regulation. In some genetic subtypes, specialists may discuss disease‑modifying approaches such as L‑serine supplementation, but this is individualized, and regular follow‑up with a neuromuscular or genetics clinic helps tailor care over time.
Non-drug treatment
Hereditary sensory and autonomic neuropathy type 1 affects how you sense pain and temperature, so everyday protection and routine checks matter. Non-drug treatments often lay the foundation for staying active, preventing injuries, and healing well. Recognizing early symptoms of Hereditary sensory and autonomic neuropathy type 1 can help you start foot protection and skin checks sooner. Plans are tailored to age, lifestyle, and mobility, and may change as needs change.
Look over the soles, heels, and between toes every day for blisters, cuts, or redness. Use a mirror or ask someone to help if reaching is hard. Catching small problems early prevents ulcers and infections.
Wear well-fitted shoes with cushioned soles and closed toes to shield numb feet. Seamless socks and soft insoles reduce rubbing that you might not feel. Avoid walking barefoot, even at home.
Use custom insoles, toe spacers, or boots to take pressure off sore spots and ulcers. This helps wounds close faster and lowers the chance they reopen.
Regular visits with a foot specialist help spot trouble areas you may miss. They can trim calluses safely and adjust footwear to prevent new injuries.
Your genes may have an impact on how drugs work for you
Drugs for hereditary sensory and autonomic neuropathy type 1 can work differently depending on gene variants that affect how your body processes medications or how nerve cells respond. Pharmacogenetic testing may guide safer dosing and drug choices, reducing side effects and improving relief.
Pharmacological treatments
Treatment for hereditary sensory and autonomic neuropathy type 1 (HSAN1) focuses on easing nerve pain and managing autonomic symptoms like dizziness on standing or bowel changes. Drugs that target symptoms directly are called symptomatic treatments. A specialized option, L-serine, may help in certain genetic forms by lowering harmful nerve lipids; this is usually guided by a neurologist. Knowing the early symptoms of hereditary sensory and autonomic neuropathy type 1 can help you and your care team tailor medicines sooner.
In some SPTLC1-related HSAN1, high-dose L-serine may lower toxic sphingolipids and potentially slow nerve damage. Small clinical studies suggest it can reduce pain or numbness, but it is not appropriate for everyone.
These medicines calm overactive nerve signals to reduce burning or shooting pain. Dosing may be increased or lowered gradually to balance pain relief with side effects like sleepiness or dizziness.
These antidepressant-class drugs are often used for nerve pain and can also help sleep. They may suit people with both pain and low mood or anxiety, though dry mouth, constipation, or lightheadedness can occur.
Lidocaine patches or capsaicin cream can target a painful area with fewer whole‑body effects. Some medicines work quickly, while others need days to build up benefit.
Genetic influences
Most cases of hereditary sensory and autonomic neuropathy type 1 (HSAN1) are caused by a single altered copy of a gene inherited from a parent, a pattern called autosomal dominant. That means each child has a 50% chance of inheriting the gene change, but the age symptoms begin and how much they affect daily life can vary widely, even within the same family. Family history is one of the strongest clues to a genetic influence. The gene changes most often involve SPTLC1 or SPTLC2, which can disturb a pathway that helps keep long sensory nerves healthy over time. Sometimes a gene change arises for the first time in a family, and rarer subtypes may involve other genes. Understanding this pattern can help families watch for early symptoms of hereditary sensory and autonomic neuropathy type 1 and consider whether genetic counseling or testing might offer clarity.
Is Hereditary sensory and autonomic neuropathy type 1 genetic?
Genetics are central in Hereditary sensory and autonomic neuropathy type 1, which is usually caused by inherited variants in specific genes. Most cases follow an autosomal dominant pattern, so a single altered gene can lead to symptoms. Genetic testing can confirm HSAN1, guide family planning, and inform prognosis.
Pharmacogenetics—how genetics influence drug effects
For people living with Hereditary sensory and autonomic neuropathy type 1 (HSAN1), genetics influence care in two main ways: the gene that causes the condition and other genes that affect how you process medicines. The SPTLC1 change that leads to HSAN1 can guide disease‑targeted care—some specialists monitor toxic deoxysphingolipid levels and may consider L‑serine supplementation to lower them, though this approach is still being studied, needs regular monitoring, and isn’t right for everyone. Separately, differences in drug‑processing genes such as CYP2D6 or CYP2C19 can shape your response to common neuropathic pain treatments, including tricyclics, some SSRIs/SNRIs, and opioid‑like options such as codeine or tramadol. People who break down these drugs very slowly may have more side effects, while very rapid processors may get little pain relief; gabapentin and pregabalin are less affected by these pathways. If carbamazepine is being considered for pain, HLA testing can reduce the risk of rare but serious skin reactions (HLA‑B*15:02 in many people of East or Southeast Asian ancestry; HLA‑A*31:01 in many people of European or Japanese ancestry). Genetic testing can sometimes identify how your body handles certain medicines, helping your doctor personalize dosing and choose safer options; pharmacogenetic testing for Hereditary sensory and autonomic neuropathy type 1 typically complements, rather than replaces, your clinical history and symptom pattern.
Interactions with other conditions
When nerve damage is already present, conditions that affect nerves or blood flow can add up; foot ulcers may linger longer and infections can be harder to spot. In Hereditary sensory and autonomic neuropathy type 1 (HSAN1), having diabetes or peripheral artery disease can heighten numbness and poor wound healing, raising the risk of serious foot problems like bone infection. Doctors call it a “comorbidity” when two conditions occur together. Alcohol-related nerve injury, vitamin B12 deficiency, and thyroid disease can also mimic or worsen neuropathy, making early symptoms of Hereditary sensory and autonomic neuropathy type 1 easy to miss. Certain medicines that can damage nerves—such as some chemotherapy drugs or excess vitamin B6—may intensify pain or numbness in people with HSAN1, so treatment plans sometimes need adjustment. Infections and skin injuries are more likely to escalate because pain signals are dulled in HSAN1, so even minor cuts on the feet deserve prompt care.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
History
Throughout history, people have described families in which several relatives lost feeling in their feet and hands, developed painless injuries, and later had trouble with balance. Community stories often described the condition as “nerves wearing out early,” especially when burns or ulcers went unnoticed. In some towns, a grandparent’s foot problems would be remembered when a grandchild showed the same early symptoms of Hereditary sensory and autonomic neuropathy type 1 (HSAN1) in their teens or adulthood.
First described in the medical literature as a cluster of inherited numbness and foot ulcers, HSAN1 was initially pieced together from case reports. Early doctors noticed that pain and temperature sensation faded first in the toes, then moved upward, and that people often lacked the usual warning signs of infection. Over time, descriptions became more precise: balance issues from nerve damage, slow-healing wounds, and fewer signs of sweating in the affected areas. Some features were observed by clinicians, while others—like burning discomfort that later gives way to numbness—came from people living with the condition.
As medical science evolved, researchers mapped out how HSAN1 tends to appear later than many childhood neuropathies. This helped separate it from other nerve conditions that look similar at first glance. Families who kept careful histories made a major difference; patterns across generations showed that when one parent was affected, each child had a chance of inheriting the condition. These family trees guided the first formal classifications and helped clinicians recognize HSAN1 even before genetic testing was available.
In recent decades, knowledge has built on a long tradition of observation. Advances in genetics identified changes in a gene involved in nerve-cell building blocks, confirming what families and clinicians suspected: HSAN1 is passed down and targets sensory and parts of autonomic function. This insight explained why people might not feel a deep cut yet also notice changes in sweating or skin warmth. Genetic testing then refined diagnosis, allowed earlier detection in relatives, and clarified that not every family shows symptoms in the same way or at the same age.
Understanding HSAN1’s history matters for care today. Earlier generations often faced infections, amputations, or severe balance problems before anyone named the cause. Now, recognizing the pattern—painless injuries, progressive numbness, foot ulcers—supports earlier foot protection, wound care, and strategies to maintain mobility. Awareness of past misunderstandings can encourage timely referrals for nerve testing and genetics, helping families plan, monitor, and reduce complications linked to this long-studied inherited neuropathy.